{"transactions":[{"id":3015779,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-10-02T20:35:13.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2020, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":12.88,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-053394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053394/doc4.xml","form_type":"4"}},{"id":3015788,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":265203,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":265203},"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015787,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":1040654,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1040654},"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015786,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":3488398,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3488398},"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015785,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":1620101,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1620101},"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015784,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":265203,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":6469911,"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015783,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":1040654,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":6204708,"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015782,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":3488398,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":5164054,"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015781,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":1620101,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":1675656,"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3015780,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T18:42:47.000Z","date":"2020-09-25","kind":"purchase","acquired":true,"shares":55555,"price":18,"value":999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":55555,"source":{"system":"sec-edgar","filing":"0001209191-20-053346","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120053346/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":3020643,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":265203,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":265203},"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020642,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":1040654,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1040654},"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020641,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":3488398,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3488398},"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020640,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":1620101,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1620101},"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020639,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":265203,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":6469356,"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020638,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":1040654,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":6204153,"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020637,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":3488398,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":5163499,"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020636,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":1620101,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":1675101,"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3020635,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T16:33:05.000Z","date":"2020-09-25","kind":"purchase","acquired":true,"shares":55000,"price":18,"value":990000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001209191-20-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000120919120052334/doc4.xml","form_type":"4"}},{"id":3131050,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2020-05-29T16:37:27.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 28, 2021, on the one year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":4.84,"expiration_date":"2027-05-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-032958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919120032958/doc4.xml","form_type":"4"}},{"id":3359965,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":6,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T18:26:54.000Z","date":"2019-11-21","kind":"other","acquired":false,"shares":3005,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of August 7, 2019, by and among Avedro, Inc. (the \"Issuer\"), Glaukos Corporation (\"Parent\") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), on November 21, 2019, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each share of common stock of the Issuer (\"Issuer Common Stock\") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock (\"Parent Common Stock\"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by InterWest Venture Management Company (\"IVMC\"). Gilbert H. Kliman transferred these shares to IVMC for no consideration pursuant to a contractual agreement between Kliman and IW10. Arnold L. Oronsky and Gilbert H. Kliman are owners, directors and officers of IVMC and as such may be deemed to beneficially own the shares held by IVMC. Each of Arnold L. Oronsky and Gilbert H. Kliman disclaim beneficial ownership of such shares except to the extend of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924319028099/doc4.xml","form_type":"4"}},{"id":3359964,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":6,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T18:26:54.000Z","date":"2019-11-21","kind":"other","acquired":false,"shares":2742239,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of August 7, 2019, by and among Avedro, Inc. (the \"Issuer\"), Glaukos Corporation (\"Parent\") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), on November 21, 2019, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each share of common stock of the Issuer (\"Issuer Common Stock\") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock (\"Parent Common Stock\"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by InterWest Partners X, LP (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924319028099/doc4.xml","form_type":"4"}},{"id":3374328,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Unsecured  Subordinated Convertible Promissory Note","published_at":"2019-11-13T02:01:55.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"price":0,"reported_value":2000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664 prior to the 1-for-15 reverse stock split that occurred on November 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Unsecured Subordinated Convertible Promissory Note converted upon the consummation of the Merger, pursuant to its terms."}],"balance_after":0,"derivative":{"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":301605},"source":{"system":"sec-edgar","filing":"0000899243-19-027153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000089924319027153/doc4.xml","form_type":"4"}},{"id":3374327,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T02:01:55.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":301605,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in connection with the Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer (formerly known as Restoration Robotics, Inc.), Radiant Merger Sub Ltd, an entity organized under the laws of Israel and Venus Concept Ltd, an entity organized under the laws of Israel (the \"Merger\"), upon the conversion of the outstanding principal and any accrued and unpaid interest of an 8% Convertible Promissory Notes issued by Venus Concept Inc., dated as of February 28, 2019 in the original principal amount of $2,000,000.00 and accrued interest income of $110,027.40. Share data reported herein reflects the 1-for-15 reverse stock split that occurred after the note conversion on November 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664 prior to the 1-for-15 reverse stock split that occurred on November 7, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities are directly held by InterWest Partners IX, LP (\"IW9\"). InterWest Management Partners IX, LLC (\"IMP9\") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP9, and Khaled A. Nasr is a Venture Member of IMP9. Gilbert H. Kliman is also a Director of the Issuer, and has filed a separate Form 4 in his own name. Each of the foregoing persons may be deemed to beneficially own the shares held by IW9, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. IW9 ceased to be a 10% owner upon closing of the Merger."}],"balance_after":658657,"source":{"system":"sec-edgar","filing":"0000899243-19-027153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000089924319027153/doc4.xml","form_type":"4"}},{"id":3398348,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-10-03T17:25:14.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 2, 2019, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":11.21,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001567619-19-019234","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000156761919019234/doc1.xml","form_type":"4"}},{"id":3431053,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Unsecured  Subordinated Convertible Promissory Note","published_at":"2019-08-22T17:58:19.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"price":2000000,"reported_value":2000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Promissory Note will convert upon consummation of the transactions contemplated in that certain Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer, Radiant Merger Sub Ltd., an entity organized under the laws of Israel and Venus Concept Ltd., an entity organized under the laws of Israel."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F2","text":"The securities are directly held by InterWest Partners IX, LP (\"IW9\"). InterWest Management Partners IX, LLC (\"IMP9\") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP9, and Khaled A. Nasr is a Venture Member of IMP9. Gilbert H. Kliman is also a Director of the Issuer, and has filed a separate Form 4 in his own name. Each of the foregoing persons may be deemed to beneficially own the shares held by IW9, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":0.4664,"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":4288164},"source":{"system":"sec-edgar","filing":"0000899243-19-022280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000089924319022280/doc4.xml","form_type":"4"}},{"id":3443476,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":3,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2019-08-08T11:10:32.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of  Common Stock with 75% warrant coverage at a price of $4.00 per unit.  There was no additional consideration paid for the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of  Common Stock with 75% warrant coverage at a price of $4.00 per unit.  There was no additional consideration paid for the warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\").  InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10.  Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name.  All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement."}],"balance_after":18750,"derivative":{"exercise_price":4.4,"exercise_date":"2019-08-06","expiration_date":"2024-08-05","underlying":"COMMON","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0000899243-19-021334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924319021334/doc4.xml","form_type":"4"}},{"id":3443475,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":3,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-08T11:10:32.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of  Common Stock with 75% warrant coverage at a price of $4.00 per unit.  There was no additional consideration paid for the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of  Common Stock with 75% warrant coverage at a price of $4.00 per unit.  There was no additional consideration paid for the warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\").  InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10.  Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name.  All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement."}],"balance_after":380224,"source":{"system":"sec-edgar","filing":"0000899243-19-021334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924319021334/doc4.xml","form_type":"4"}},{"id":3506616,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2019-05-31T18:30:40.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 30, 2020, on the one year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":4.97,"expiration_date":"2026-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-033727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919119033727/doc4.xml","form_type":"4"}},{"id":3649730,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series CC Convertible Preferred Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":171318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":171318},"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3649729,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series BB Convertible Preferred Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":222119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":222119},"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3649728,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series AA Convertible Preferred Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":2247190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2247190},"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3649727,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":171318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":2742239,"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3649726,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":222119,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":2570921,"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3649725,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":2,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":3,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":5,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:10:45.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":2247190,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners X, LP (\"InterWest X\"). InterWest Management Partners X, LLC (\"IMP X\") as the general partner of InterWest X may be deemed to beneficially own the shares held by InterWest X. Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP X, and Keval Desai and Khaled A. Nasr are venture members of IMP X. Messrs. Kliman, Oronsky, Desai and Nasr may be deemed to beneficially own the shares held by InterWest X. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":2348802,"source":{"system":"sec-edgar","filing":"0001209191-19-011329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919119011329/doc4.xml","form_type":"4"}},{"id":3785856,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":3,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T16:33:49.000Z","date":"2018-10-18","kind":"sale","acquired":false,"shares":26465,"price":12.001,"value":317606.465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reflected is the weighted-average sale price for shares sold.  The range of sale prices for the transactions reported was $12.00 to $12.03 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\").  InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10.  Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement."}],"balance_after":1362327,"source":{"system":"sec-edgar","filing":"0000899243-18-027169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924318027169/doc4.xml","form_type":"4"}},{"id":3785855,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":3,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T16:33:49.000Z","date":"2018-10-18","kind":"sale","acquired":false,"shares":210800,"price":12.0717,"value":2544714.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average sale price for shares sold.  The range of sale prices for the transactions reported was $12.00 to $12.30 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\").  InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10.  Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement."}],"balance_after":1388792,"source":{"system":"sec-edgar","filing":"0000899243-18-027169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924318027169/doc4.xml","form_type":"4"}},{"id":3795886,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-10-05T18:07:20.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 3, 2018, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":22.65,"expiration_date":"2028-10-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001567619-18-003783","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000156761918003783/doc1.xml","form_type":"4"}},{"id":3817946,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-12T19:16:36.000Z","date":"2018-09-10","kind":"purchase","acquired":true,"shares":58824,"price":17,"value":1000008.0,"ownership":{"direct":false,"nature":"InterWest Partners IX, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by InterWest Partners IX, L.P. is a California limited partnership (\"InterWest\"), whose general partner is InterWest Management Partners IX, LLC, a California limited liability company.  Dr. Oronsky, one of the Company's directors, currently serves as a Managing Director of InterWest. Each managing director and venture member of InterWest Management Partners IX, LLC shares voting and investment power with respect to the securities held by InterWest and disclaims beneficial ownership of such shares except to the extent of his or her pecuniary interest therein."}],"balance_after":388766,"source":{"system":"sec-edgar","filing":"0001567619-18-002466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000156761918002466/doc1.xml","form_type":"4"}},{"id":3832751,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":3,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":5,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T16:24:22.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":1098901,"price":1.82,"value":1999999.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\").  InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10.  Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name.  All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement."}],"balance_after":3552239,"source":{"system":"sec-edgar","filing":"0000899243-18-023312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000089924318023312/doc4.xml","form_type":"4"}},{"id":3846121,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":3,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":4,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-13T22:20:54.000Z","date":"2018-08-09","kind":"purchase","acquired":true,"shares":2000000,"price":1.5,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired in connection with an underwritten public offering of common stock which is scheduled to close on August 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"IW9\"). InterWest Management Partners IX, LLC (\"IMP9\") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. Arnold L. Oronsky and Gilbert H. Kliman are managing director of IMP9, and Khaled A. Nasr is a Venture Member of IMP9. Each of the foregoing persons may be deemed to beneficially own the shares held by IW9 and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":5355786,"source":{"system":"sec-edgar","filing":"0001567619-18-000665","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000156761918000665/doc1.xml","form_type":"4"}},{"id":3848508,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2018-08-09T14:00:41.000Z","date":"2018-08-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person ceased to be a director of the Issuer on May 10, 2018. As such all previously issued NQ Stock Options (right to buy) expired on 08/08/2018."}],"balance_after":0,"derivative":{"exercise_price":26.36,"exercise_date":"2015-06-02","expiration_date":"2018-08-08","underlying":"Common","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-021817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000089924318021817/doc4.xml","form_type":"4"}},{"id":3848507,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-09T14:00:41.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":10000,"price":26.7721,"value":267721.0,"ownership":{"direct":true},"balance_after":2479,"source":{"system":"sec-edgar","filing":"0000899243-18-021817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000089924318021817/doc4.xml","form_type":"4"}},{"id":3848506,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-09T14:00:41.000Z","date":"2018-08-07","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12479,"source":{"system":"sec-edgar","filing":"0000899243-18-021817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000089924318021817/doc4.xml","form_type":"4"}},{"id":3911222,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2018-06-01T17:10:58.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 31, 2019, on the one year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":15.8,"expiration_date":"2025-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-034770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919118034770/doc4.xml","form_type":"4"}},{"id":4184758,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"reported_value":1183713.69,"ownership":{"direct":true},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F4","text":"The amount reported in column 5 is the principal amount of Reporting Person's Convertible Promissory Note (the \"Note\"). The outstanding principal and accrued interest of the Note automatically converted into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the Issuer's IPO upon the closing of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The amount reported in column 5 is the principal amount of Reporting Person's Convertible Promissory Note (the \"Note\"). The outstanding principal and accrued interest of the Note automatically converted into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the Issuer's IPO upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The amount reported in column 5 is the principal amount of Reporting Person's Convertible Promissory Note (the \"Note\"). The outstanding principal and accrued interest of the Note automatically converted into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the Issuer's IPO upon the closing of the IPO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The amount reported in column 5 is the principal amount of Reporting Person's Convertible Promissory Note (the \"Note\"). The outstanding principal and accrued interest of the Note automatically converted into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the Issuer's IPO upon the closing of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":7,"underlying":"Common Stock","underlying_shares":170028},"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4184757,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":1647297,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The expiration date is not relevant to the conversion of these securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1647297},"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4184756,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":1538461,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The expiration date is not relevant to the conversion of these securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1538461},"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4184755,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":170028,"price":7,"value":1190196.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":3355786,"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4184754,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":1647297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":3185758,"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4184753,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":5,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":6,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:44:56.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":1538461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":1538461,"source":{"system":"sec-edgar","filing":"0001140361-17-038922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038922/doc1.xml","form_type":"4"}},{"id":4186564,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":153874,"kind":"organization","name":"InterWest Partners IX, LP","position":1,"cik":"0001398928","reported_name":"InterWest Partners IX, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153875,"kind":"organization","name":"InterWest Management Partners IX, LLC","position":2,"cik":"0001398927","reported_name":"InterWest Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":3,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":4,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":5,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":6,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2017-10-13T23:01:10.000Z","date":"2017-10-11","kind":"other","acquired":true,"price":1183713.69,"reported_value":1183713.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were originally acquired from the Issuer on September 6, 2017; however, the conversion price was set upon the pricing of the Issuer's Initial Public Offering (the \"IPO\")."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"The amount reported represents the principal amount of the Reporting Person's Convertible Promissory Note (the \"Note\") only. Accrued interest of 5% per year based on the actual number of days outstanding through the conversion date will also convert."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The amount reported represents the principal amount of the Reporting Person's Convertible Promissory Note (the \"Note\") only. Accrued interest of 5% per year based on the actual number of days outstanding through the conversion date will also convert."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The outstanding principal and accrued interest of the Note automatically converts into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the IPO upon the closing of the IPO; if not so converted, the Note has a maturity date of September 6, 2018, at which time it will automatically convert into shares of the Issuer's capital stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The outstanding principal and accrued interest of the Note automatically converts into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the IPO upon the closing of the IPO; if not so converted, the Note has a maturity date of September 6, 2018, at which time it will automatically convert into shares of the Issuer's capital stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The outstanding principal and accrued interest of the Note automatically converts into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the IPO upon the closing of the IPO; if not so converted, the Note has a maturity date of September 6, 2018, at which time it will automatically convert into shares of the Issuer's capital stock."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F2","text":"The amount reported represents the principal amount of the Reporting Person's Convertible Promissory Note (the \"Note\") only. Accrued interest of 5% per year based on the actual number of days outstanding through the conversion date will also convert."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The convertible promissory note is directly held by InterWest Partners IX, LP (\"InterWest IX\"). InterWest Management Partners IX, LLC (\"IMP IX\"), as the general partner of InterWest IX, may be deemed to beneficially own the shares held by InterWest IX. Philip Gianos, Arnold Oronsky, Gilbert Kliman, W. Stephen Holmes and Khaled Nasr are managing directors of IMP IX, and as such may be deemed to beneficially own the shares held by InterWest IX. Each of the foregoing persons disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"derivative":{"exercise_price":7,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001140361-17-038669","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038669/doc1.xml","form_type":"4"}},{"id":4199038,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-09-29T19:16:52.000Z","date":"2017-09-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":6000,"derivative":{"exercise_price":6.71,"expiration_date":"2027-09-26","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001140361-17-037014","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000114036117037014/doc1.xml","form_type":"4"}},{"id":4292940,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2017-06-05T18:15:11.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":12000,"derivative":{"exercise_price":149.22,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-17-037537","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917037537/a4.xml","form_type":"4"}},{"id":4292939,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T18:15:11.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":335,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to receive common stock in lieu of cash for board retainers and fees otherwise payable in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are beneficially owned by InterWest Venture Management Company (\"IVMC\"). The Reporting Person is an officer and director of IVMC and may be deemed to own beneficially the shares held by IVMC."}],"balance_after":1338,"source":{"system":"sec-edgar","filing":"0001104659-17-037537","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917037537/a4.xml","form_type":"4"}},{"id":4296357,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2017-06-02T18:01:52.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on June 2, 2018, on the one year anniversary of the grant date."}],"balance_after":7500,"derivative":{"exercise_price":5.9,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-037409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919117037409/doc4.xml","form_type":"4"}},{"id":4344479,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to buy Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":false,"shares":91,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are owned by II8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4.5395,"exercise_date":"2012-05-02","expiration_date":"2017-05-02","underlying":"Common","underlying_shares":91},"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4344478,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to buy Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":false,"shares":328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are owned by IIQ8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4.5395,"exercise_date":"2012-05-02","expiration_date":"2017-05-02","underlying":"Common","underlying_shares":328},"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4344477,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to buy Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":false,"shares":11476,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are owned by IW8. The General Partner of IW8 is InterWest Management Partners VIII, LLC (\"IMP8\"). The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4.5395,"exercise_date":"2012-05-02","expiration_date":"2017-05-02","underlying":"Common","underlying_shares":11476},"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4344476,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":true,"shares":28,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents cashless exercise of a warrant by InterWest Investors VIII, LP (\"II8\").  63 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 91 warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are owned by II8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":11208,"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4344475,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":true,"shares":101,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents cashless exercise of a warrant by InterWest Investors Q VIII, LP (\"IIQ8\").  227 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 328 warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are owned by IIQ8. The General Partner of IW8 is IMP8. The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":40181,"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4344474,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2017-04-26T13:07:05.000Z","date":"2017-04-24","kind":"other","acquired":true,"shares":3559,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents cashless exercise of a warrant by InterWest Partners VIII, LP (\"IW8\").  7,917 shares of common stock were withheld by the issuer at the market price of $6.58 per share to fund the cashless exercise of 11,476 warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are owned by IW8. The General Partner of IW8 is InterWest Management Partners VIII, LLC (\"IMP8\"). The Reporting Person is a Managing Director of IMP8, shares voting and investment power with the other Managing Directors of IMP8, and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1404515,"source":{"system":"sec-edgar","filing":"0000899243-17-010898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317010898/doc4.xml","form_type":"4"}},{"id":4371413,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-03-27T19:07:03.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 3 year period: 1/36th on December 21, 2016 after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":12000,"derivative":{"exercise_price":7.88,"expiration_date":"2027-03-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-17-013499","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207833/000114036117013499/doc1.xml","form_type":"4"}},{"id":4408930,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":1,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-03-02T19:25:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option becomes exercisable on February 28, 2018."}],"balance_after":8000,"derivative":{"exercise_price":7.75,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-17-006170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317006170/doc4.xml","form_type":"4"}},{"id":4580704,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":373803,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant  to the Registration Statement, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant  to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant  to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant  to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":373803},"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}},{"id":4580703,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":464494,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":464494},"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}},{"id":4580702,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":1615041,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-213551) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-213551) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-213551) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-213551) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1615041},"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}},{"id":4580701,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":373803,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of the issuer's Series E Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant  to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":2453338,"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}},{"id":4580700,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":464494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":2079535,"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}},{"id":4580699,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":130685,"kind":"organization","name":"INTERWEST PARTNERS X LP","position":1,"cik":"0001443898","reported_name":"INTERWEST PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130684,"kind":"organization","name":"InterWest Management Partners X, LLC","position":2,"cik":"0001460207","reported_name":"InterWest Management Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172437,"kind":"person","name":"GIANOS PHILIP T","position":3,"cik":"0001207831","reported_name":"GIANOS PHILIP T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172438,"kind":"person","name":"Holmes W Stephen","position":4,"cik":"0001293923","reported_name":"Holmes W Stephen","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21207,"kind":"person","name":"Kliman Gilbert H","position":5,"cik":"0001293171","reported_name":"Kliman Gilbert H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":146229,"kind":"person","name":"ORONSKY ARNOLD L","position":6,"cik":"0001207833","reported_name":"ORONSKY ARNOLD L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130687,"kind":"person","name":"Desai Keval","position":7,"cik":"0001553019","reported_name":"Desai Keval","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130686,"kind":"person","name":"NASR KHALED","position":8,"cik":"0001276600","reported_name":"NASR KHALED","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-12T17:34:44.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":1615041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on October 12, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-213551) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by InterWest Partners X, L.P. (\"IW10\"). InterWest Management Partners X, LLC (\"IMP10\") is the general partner of IW10. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of IMP10, and Keval Desai and Khalad A. Nasr are venture members of IMP10. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any.  The reporting persons have designated a representative, currently Doug Fisher, a consultant of InterWest Venture Management Co., to serve on the issuer's board of directors.  This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes."}],"balance_after":1615041,"source":{"system":"sec-edgar","filing":"0001209191-16-145722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460207/000120919116145722/doc4.xml","form_type":"4"}}]}